Skip to content

Comparing the effect of intraveous versus perineural magnesium sulphate as adjuvant in supraclavicular block

Comparative evaluation between perineural magnesium sulphate and intravenous magnesium sulphate as an adjuvant to Ropivacaine in USG guided supraclavicular brachial plexus block. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/060211
Enrollment
42
Registered
2023-11-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: M844- Pathological fracture, not elsewhere classified

Interventions

Intervention1: Injection Ropivacaine 0.75% 20 ml +150 mg of Magnesium sulphate in block: Intravenous line secured with 18G cannula in the unaffected limb and given I.V. fluids according to the require

Sponsors

Rajarajeswari medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Both sexes, aged between 18-60 years belonging to ASA I and II those who are posted for elective upper limb surgeries (Surgeries of distal humerus, elbow, forearm and hand)

Exclusion criteria

Exclusion criteria: 1. Patient refusal, 2. Pregnant and lactating mothers, 3. ASA III and IV, 4. Known Allergy/contraindication to local anesthetic, 5. Patients having peripheral neuropathy and preexisting neurological defects in upper limbs, 6. Known cases of seizure disorder, 7. Patients with coagulopathies and patients on chronic anticoagulation therapy, 8.Patients with psychiatric illness and local skin infections.

Design outcomes

Primary

MeasureTime frame
To evaluate and compare the duration of analgesia by intravenous versus perineural MgSO4.Timepoint: VAS score in first 24 hours post surgery.

Secondary

MeasureTime frame
To assess the onset and duration of sensory and motor blockade. To study analgesic consumption in 24 hours and any side effects. Timepoint: Intraoperative and postoperative period 24 hrs post surgery

Countries

India

Contacts

Public ContactDr Lini Rajan

Rajarajeswari medical college and hospital

sudheerramegowda81@gmail.com9741117754

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026